HB 862 – Improve Access to Patient Care

HB 862 – Improve Access to Patient Care

Primary House Sponsors: Rep. Wayne Sasser (Cabarrus, Rowan, Stanly)

 

Summary

This bill makes a series of revisions to statutes governing clinical pharmacist practitioners. Specifically, this bill:

  • Defines “clinical pharmacist practitioner” as a licensed pharmacist who meets all of the following requirements: (1) provides collaborative care in accordance with written collaborative practice agreement with one or more physicians; (2) has registered with the NC Board of Pharmacy Clinical Pharmacist Practitioner Registry; (3) meets and maintains the required annual professional development requirements; (4) maintains good standing with the Board of Pharmacy; and (5) practices in accordance with statutory requirements and rules established by the joint subcommittee of the NC Medical Board and the NC Board of Pharmacy.
  • Defines collaborative care services as “patient care services authorized by a physician and delegated to a pharmacist for the purpose of drug therapy and disease management” and further specifies that under a collaborative practice agreement, “a supervising physician may delegate to a licensed pharmacist any patient care services that the supervising physician deems appropriate.”
  • Permits clinical pharmacist practitioners to provide patient care services provided that (1) the NC Medical Board and NC Board of Pharmacy have adopted rules developed by a joint subcommittee governing the use and oversight of collaborative practice in patient care settings and that the Boards must determine to be in the best interest of patient health and safety and (2) the clinical pharmacist practitioner is registered with the NC Board of Pharmacy and maintains annual requirements.
  • Requires the supervising physician to evaluate the provision of collaborative care services consistent with rules established by the Medical Board and Board of Pharmacy.
  • Specifies that any drug therapy order for medications, tests, or devices written by a clinical pharmacist practitioner shall be deemed to have been authorized by the collaborating physician.
  • Requires the supervising physician to conduct periodic review and evaluation of the clinical pharmacist practitioner’s prescribing patterns.
  • Permits institutional and group practice to implement an institution-wide, multiprovider collaborative practice agreement for the care of patients provided the practice develops a policy for oversight and the clinical pharmacist practitioners engaged in the agreement are evaluated by an appointed supervising physician.

 

Movement

Filed – 5/4/2021


HB 858 – Permit Cannabis Medical Research Studies

HB 858 – Permit Cannabis Medical Research Studies

Primary House Sponsors: Rep. Grier Martin (D-Wake); Rep. John Faircloth (R-Guilford); Rep. Mary Belk (D-Mecklenburg)

Summary

This bill:

  • Establishes the NC Cannabis Alternative Treatment Act to permit the use of cannabis as an alternative treatment for medical conditions.
  • Requires DHHS to create a Cannabis Alternative Treatment database registry for the registration of physicians, caregivers, and patients.
  • Requires a written certification or statement signed by a patient’s physician that, in the physician’s professional opinion, the patient has a medical condition and the potential health benefits of the medical use of cannabis would likely outweigh the health risks for the patient.
  • Permits physicians to approve dispensation of cannabis acquired from another jurisdiction to a registered caregiver.
  • Provides civil, criminal, and disciplinary immunity for physicians who approve or recommend the use of cannabis or provide a written certification for the use of cannabis.
  • Establishes the NC Cannabis Research Program, which would permit any physician who issues a written certification to a patient to be allowed to participate in objective scientific research regarding the administration of cannabis as part of medical treatment.

 

Movement

Filed – 5/4/2021


HB 855 – Give Clinical Researchers HIE Network Access

HB 855 – Give Clinical Researchers HIE Network Access

Primary House Sponsors: Rep. Verla Insko (D-Orange); Rep. Jon Hardister (R-Guilford); Rep. Carla Cunningham (D-Mecklenburg)

Summary

This bill permits a clinical researcher who is conducting or preparing to conduct a clinical investigation approved by an institutional review board to connect to the HIE Network to access protected health information about participants who are enrolled, or applicants who are seeking to enroll, in the clinical investigation provided that the clinical researcher demonstrates compliance with the following criteria: (1) has obtained a signed release from each applicant/participant; (2) is financially independent from the funding sponsor of the clinical investigation; (3) agrees to access the HIE Network on a per-individual basis; and (4) agrees to limit the use of each applicant’s/participant’s protected health information to one or more specified purposes.

 

Movement

Filed – 5/4/2021


HB 843 – Certificate of Need Modifications

HB 843 – Certificate of Need Modifications

Primary House Sponsors: Rep. Harry Warren (R-Rowan); Rep. Keith Kidwell (R-Beaufort, Craven); Rep. William Richardson (D-Cumberland); Rep. Wayne Sasser (R-Cabarrus, Rowan, Stanly)

 

 

 

Summary

This bill:

  • Modifies a series of defined terms.
  • Exempts from certificate of need review a new institutional health service if DHHS receives prior written notice from the entity stating that the new service is required to develop, acquire, construct, expand, or release a health service facility or service that obtained certificate of need approval prior to January 1, 2022 as an ambulatory surgical facility.
  • Exempts from certificate of need review a capital expenditure that exceeds $4M if certain specified conditions are met.
  • Exempts from certificate of need review services or facilities for which a certificate of need has already been issued when those services or facilities are replaced, renovated, or relocated to another site in the same county where need was originally determined.
  • Exempts from certificate of need review the construction, development, acquisition, or establishment of an ambulatory surgical facility in a county with a population of 100K or more if certain specified conditions are met.
  • Specifies when a certificate of need for the construction of a health service facility expires if the holder of the certificate of need fails to initiate construction of the project within specified time frames.
  • Prohibits DHHS from issuing or renewing a license to operate an ambulatory surgical facility developed, acquired, or replaced on or after January 1, 2022 unless the license application includes (1) a commitment that the Medicare allowable amount for self-pay and Medicaid surgical cases minus all revenue collected from self-pay and Medicaid surgical cases will be equal to either 4% of the total revenue collected for all surgical cases performed in the facility/proposed facility or the percentage of charity care ambulatory surgery services provided by the affiliated hospital, whichever is greater; (2) a commitment to report total number of cases for certain specified payer categories for each year of operation; and (3) a commitment to report utilization and payment data for services provided by the facility to the statewide data processor.

 

Movement

Filed – 5/4/2021


HB 841 – DHHS Compliance Review/Jail Suicide Attempts

HB 841 – DHHS Compliance Review/Jail Suicide Attempts

Primary House Sponsors: Rep. Carla Cunningham (D-Mecklenburg); Rep. Amos Quick, III (D-Guilford); Rep. Raymond Smith, Jr. (D-Sampson, Wayne); Rep. Kandie Smith (D-Pitt)

 

Summary

This bill requires DHHS to conduct a suicide prevention program compliance review following a report of an attempted suicide by an inmate in the custody of a local confinement facility in the state.

 

This bill appropriates $186,702 in recurring funds for each year of the 2021-2023 fiscal biennium to DHHS to be used to hire two full-time Jail Inspectors.

 

This bill also appropriates $110,296 in recurring funds for each year of the 2021-2023 fiscal biennium to DHHS to be used to hire a full-time Facility Compliance Consultant to perform compliance reviews of each reported attempted suicide.

 

Movement

Filed – 5/4/2021


HB 818 – Regulate Cannabinoid Products

HB 818 – Regulate Cannabinoid Products

Primary House Sponsors: Rep. Wayne Sasser (R-Cabarrus, Rowan, Stanly); Rep. Chris Humphrey (R-Lenoir, Pitt); Rep. Jeffrey McNeely (R-Iredell)

 

Summary

This bill requires the Board of Agriculture to adopt rules to establish a voluntary certification program for practices related to manufacturing, packaging, or labeling operations for cannabinoid-related compounds derived from hemp.

 

This bill also prohibits the manufacture, sale, delivery, holding or offering for sale of any cannabinoid-related compounds that are falsely certified.

 

This bill also specifies that hemp-containing products are not considered to be adulterated or misbranded solely based on the inclusion of hemp or any hemp derivative.

 

Movement

Filed – 5/4/2021


HB 817 – Allow Pharmacists to Dispense Contraceptives

HB 817 – Allow Pharmacists to Dispense Contraceptives

Primary House Sponsors: Rep. Julie von Haefen (D-Wake); Rep. Deb Butler (D-New Hanover); Rep Susan Fisher (D-Buncombe)

 

 

Summary

This bill

  • Requires the State Health Director to issue a statewide standing order authorizing licensed pharmacists to dispense self-administered hormonal contraceptives. The State Health Director must consult with the NC Medical Board, the NC Board of Pharmacy, and DHHS to develop written protocols to dispense a self-administered hormonal contraceptive, including: (1) a risk assessment questionnaire, (2) requirements for the written records of the request, and (3) the length of time a written record must be maintained by the pharmacist.
  • Requires the statewide standing order to detail information the dispensing pharmacist must give to the patient concerning the contraceptive, including: (1) the importance of obtaining recommended tests and screening from the patient’s primary care provider or other provider who specializes in women’s health; (2) the effectiveness of long-acting reversible contraceptives as an alternative to self-administered hormonal contraceptives; (3) when to seek emergency medical services as a result of administering a self-administered hormonal contraceptive, and (4) the risk of contracting a sexually transmitted infection and ways to reduce that risk.
  • Authorizes a licensed pharmacist to dispense a self-administered hormonal contraceptive to an individual if the contraceptive is administered in compliance with a statewide standing order issued by the State Health Director.
  • Requires pharmacists to provide a risk assessment questionnaire to any patient who requests the questionnaire prior to dispensing the self-administered hormonal contraceptive. If the pharmacist determines that it is unsafe to dispense the self-administered hormonal contraceptive after reviewing the completed questionnaire, the pharmacist must not dispense the contraceptive and must refer the patient to the patient’s primary care provider or another qualified health care provider.
  • Requires pharmacists who dispense a contraceptive to create and maintain records, inform the patients about the proper administration and storage of the contraceptive, potential side effects, and the need to use other methods of contraception if appropriate. Pharmacists must also provide certain specified information, including a copy of patient records and a copy of the risk assessment questionnaire completed by the patient upon request by the patient.
  • Requires insurers providing health benefit plans to provide coverage for nonprescription contraceptive drugs, devices, and products.
  • Prohibits health benefit plans from imposing any deductible, coinsurance, copayment, or other cost-sharing requirement on coverage for prescription contraception drugs or devices, including any self-administered hormonal contraceptive.

 

Movement

Filed – 5/4/2021


HB 816 – Broadband Empowerment Act

HB 816 – Broadband Empowerment Act

Primary House Sponsors: Rep. Brian Farkas (D-Pitt); Rep. Jason Saine (R-Montgomery, Richmond, Stanly); Rep. Jake Johnson (R-Henderson, Polk, Transylvania); Rep. Rachel Hunt (D-Mecklenburg)

 

Summary

This bill authorizes the Department of Transportation to construct conduit for telecommunications cables within the State right-of-way where such construction and leasing is not otherwise prohibited by any other federal or State law.

 

Movement

Filed – 5/4/2021


HB 809 – NC Healthy Family Act

HB 809 – NC Healthy Family Act

Primary House Sponsors: Rep. Carla Cunningham (D-Mecklenburg); Rep. Raymond Smith, Jr. (D-Sampson, Wayne); Rep. Linda Cooper-Suggs (D-Wilson); Rep. James Gailliard (D-Nash)

 

Summary

This bill expands access to Medicare benefits to individuals between the ages of 19 and 65 with modified adjusted gross incomes that are at or below 133% of the federal poverty guidelines.

 

Movement

Filed – 5/4/2021


HB 800 – Women’s Cancer Research & Prevention Task Force

HB 800 – Women’s Cancer Research & Prevention Task Force

Primary House Sponsors: Rep. Becky Carney (D-Mecklenburg); Rep. Mary Belk (D-Mecklenburg); Rep. Kristin Baker, MD (R-Cabarrus); Rep. Susan Fisher (D-Buncombe)

 

Summary

This bill establishes the Women’s Cancer Research and Prevention Task Force within DHHS and specifies the Task Force’s duties, including to identify evidence-based strategies for controlling risks and preventing cancer development in women, adopt and promote a statewide comprehensive Women’s Cancer Prevention Plan, identify and facilitate commitments to implement the Plan, and to identify, facilitate, and promote cancer research.

 

This bill also establishes additional details regarding the Task Force such as membership, quorum requirement, and compensation for Task Force members.

 

Movement

Filed – 5/3/2021